Microcrystalline Cellulose Market Report Scope & Overview:

The Microcrystalline Cellulose Market size was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.12 billion by 2032, growing at a CAGR of 7.23% over the forecast period of 2025-2032.

 The microcrystalline cellulose market analysis indicates that the surge in pharmaceutical use of tablet formulations is a factor hampering the market performance. Microcrystalline cellulose (MCC) is one of the most commonly utilized materials in oral solid dosage forms as a binder, filler, and disintegrant, as it has good flow, compressibility, and compatibility with active pharmaceutical ingredients (APIs). People are increasingly more in need of tablets and capsules as the global population becomes older and there is a higher incidence of chronic disease. In addition, the increasing manufacturing of generic pharmaceuticals and OTC medications, especially in developing countries, has only added to MCC use. MCC acts as a binding material to give tablet stability and uniform drug delivery, and it helps in high-speed tablet manufacturing; hence, pharmaceutical manufacturers prefer MCC, and it has become an integral part of current drug formulation, which drive the microcrystalline cellulose market growth.

The FDA cites that 91 percent of all prescriptions in the U.S. are filled with generic drugs, and over 32,000 generic pharmaceuticals have been approved to date. Since most of these generics are solid oral dosage forms (tablets and capsules), MCC is an important excipient in these products.

Market Dynamics:

Drivers

  •  Growing Adoption in Processed and Functional Foods Drives the Market Growth

With changing consumer preferences towards healthy and natural ingredients, microcrystalline cellulose (MCC) is becoming an increasingly important functional food novel ingredient in the processed food sector. It is suitable for low-fat, low-calorie, and high-fiber formulations without sacrificing texture or taste. Maltodextrin and condensed milk MCC enable structure and creaminess in reduced-fat products such as dressings, sauces, dairy desserts, and frozen foods to aid manufacturers with the appeal of the product while reducing fat and calorie content. Besides, its role in improving moisture-retaining and shelf properties helps make processed foods more stable during storage and transport. The growing clean-label trends, the increasing popularity of vegan and gluten-free places, and the regulatory pressures to adopt healthier formulations have increased the need for plant-derived, non-GMO, and allergen-free additives, such as MCC. MCC fits right in with this movement, as consumers are more discerning than ever about labels, and they want familiar and natural products.

 JRS Rettenmaier, a global leader in cellulose-based functional ingredients, expanded its food-grade MCC production facilities in Missouri, USA, in 2022. This investment was aimed at boosting local supply capacity and improving service to North American food and beverage manufacturers.

Restrain

  • High Production Cost and Energy-Intensive Process May Hamper the Market Growth

The manufacture of Microcrystalline Cellulose necessitates the bonding of several layers of glass and plastic materials such as polycarbonate and polyurethane under high pressure. These materials are costly, and the production process is complicated and has high energy consumption. Additionally, customization requirements for various threat levels (NIJ or EN standards) increase cost, making it unaffordable for many institutions. The situation is compounded in developing countries. Even though they have high-security requirements, this limits adoption in cost-sensitive applications such as public transport or small-scale commercial buildings. The setup and technology needed are also high-cost cost which forms a barrier for new players.

Opportunities                                          

  •  Expansion into Nutraceuticals and Dietary Supplements Creates an Opportunity in the Market

Increasing consumer awareness about preventive health and fitness is driving the demand for vitamins, minerals, and herbal supplements. In nutraceuticals, MCC is employed as a bulking agent as well as a disintegrant in caplets, softgels, and chewables, among others. Due to its ability to improve the stability of tablets as well as ensure a consistent dose, it proves even more useful in this area.

MCC serves a tripartite role in any given dosage form by acting as a bulking agent, binder, and disintegrant, and is therefore a common ingredient in caplets, tablets, chewables, and even powdered formulations. It functions to bind to maintain structural integrity, facilitate uniform distribution of active ingredients, enhance mouthfeel in chewable forms, and promote disintegration of the tablets for optimal nutrient release, which drives the microcrystalline cellulose market trends.

For instance, in 2023, DFE Pharma launched a high-performance MCC grade for nutraceuticals, Pharmacel 112, to further strengthen its share of functional health products.

Segmentation Analysis:

By Source

Wood-based held the largest microcrystalline cellulose market share, around 67%, in 2024. This dominance is attributed to the rising need for better protection concerning military personnel, government officials, and other high-profile individuals as geopolitical tensions, threats of terrorism, and civil unrest continue to rise. Microcrystalline Cellulose is an essential aspect of armored vehicles; it provides ballistic protection while still allowing the vehicle to see outside and have its physiological structure like others. Several fleets are being upgraded with a massive investment boost to state and even private sectors that provide advanced glazing systems that comply with stringent international safety standards. The segment also continues to lead in the market, boosted by technological developments in lightweight, multi-layered glass materials that have expanded their use in high-performing defense vehicles and even luxury low-profile vehicles.

Non-wood-based products held a significant microcrystalline cellulose market share. It is owing to its favor, in particular, for its use in formulations with hypoallergenic, organic, or GM-free ingredients. Finally, with increased focus on sustainability, industries are investigating other raw materials to decrease reliance on wood pulp and broaden their supply line. In areas lacking forestry resources or where cotton byproducts are more readily available, non-wood MCC is also gaining traction. Together, these factors are leading to the increasing use of non-wood-based MCC in developed as well as emerging markets.

By Application

The pharmaceutical segment held the largest market share, around 34%, in 2024.  It is due to its great binding, compressibility, and disintegration characteristics, it can be used for the formulation of tablets and capsules, providing reproducible drug delivery and structural stability. Given the ongoing increase in the need for generic medicines, over-the-counter drugs, and treatments for chronic diseases around the world, especially in aged populations, MCC is still a vital component of modern drug formulation. The trend towards high-speed manufacturing of tablets, as well as the increasing demand by manufacturers for multi-layer and controlled-release tablets, has led to increased utilization of MCCs.

Personal Care & Cosmetics holds a significant market share in the microcrystalline cellulose market. It is due to the growth of natural, sustainable, and functional ingredients for beauty and hygiene applications that continues to prosper. MCC is commonly used in formulation as a thickening agent, absorbent, anti-caking agent, and exfoliant, providing a non-toxic, plant-derived alternative to synthetics. Due to its silky texture, cosmetic stabilizer it is ideal for facial powders, creams, lotions, and toothpaste because it absorbs moisture. McCarron, Nature categorizes MCC under organic ingredients as one of the options that manufacturers are using MCC for sustainable personal care items to meet consumer demands for sustainable and label-friendly goods.

Regional Analysis:

North America microcrystalline cellulose market held the largest market share, around 39.36%, in 2024. It is the need for well-established and innovation-driven industries is mainly owed to mature industries like pharmaceuticals, food and beverage industry and personal care. Excipients used in tablets, functional foods, and cosmetics require high-purity, reproducible, and plant-sourced origins in these sectors. MCC, which is primarily sourced from cellulose from wood pulp, is well-aligned with North American trends toward clean label, non-GMO, and sustainable formulations. The stringent regulations placed upon pharmaceutical excipients in the US FDA are also driving local manufacturers to utilize tried and tested ingredients that have been cited as Generally Recognized as Safe (GRAS), such as microcrystalline cellulose (MCC), which has desirable binding, compressibility, and flow properties.

In October 2023, Roquette launched three innovative MCC analytical grades that protect from moisture MICROCEL 103 SD, 113 SD, and 102 SD. They were intended for a growing regional market that requests nutrient delivery systems for humidity-sensitive nutraceuticals and pharmaceuticals.

The U.S Microcrystalline Cellulose market size was USD 329 million in 2024humidity-sensitive, and is expected to reach USD 577 million by 2032 and grow at a CAGR of 7.28% over the forecast period of 2025-2032. MCC demand in the U.S. benefits from consumer trends toward clean-label foods and plant-based products, as well as from increasingly high pharmaceutical standards. This is complemented by various government-backed sustainability initiatives that help foster the domestic production of management-controlled corporations (MCCs) as well. The U.S. EPA Green Chemistry Program provides incentives for greener chemical manufacturing processes, pushing MCC producers towards better purification and less waste, consistent with bio-based material policies.

Asia Pacific microcrystalline cellulose market held a significant market share and is the fastest-growing segment in the forecast period. The rising emphasis on localized drug manufacturing and generics manufacturing for exports in nations like India and China is resulting in persistent demand for quality excipients such as MCC. Simultaneously, rising health consciousness and a growing middle-class population are supporting demand for dietary supplements, in which MCC is also employed in tablets, chewables, drug delivery systems, and capsules as a bulking agent and binder. Similarly, the food industry is driving the trend primarily with fat and fiber-removed food products and clean-label products.

Europe held a significant market share in the forecast period. It is due to the well-established pharmaceutical, nutraceutical, food, and personal care industries in the region. Such sectors require high-purity, stable, and certified excipients and additives, especially for clean-label and environmentally friendly formulations. Additionally, the European market is driven by vibrant consumer demand towards organic, non-GMO, and biodegradable products, particularly in cosmetics and food. This drives the industry to use MCC that comes from wood or other sustainable plant sources to meet these desires. MCC is commonly used in Europe for producing tablets, dietary supplements, fat-free food formulations, and environmentally friendly cosmetics.

Key Players:

The major microcrystalline cellulose companies are DuPont, FMC Corporation, JRS Pharma, Roquette, DFE Pharma, Asahi Kasei Corporation, Avantor Inc., Mingtai Chemical Co., Ltd., Sigachi Industries, and Libraw Pharma

Recent Development:

  • In 2024, Asahi Kasei introduced Ceolus  MCC with ≤0.1ppm nitrite as a solution to mitigate the risk of nitrosamine impurities in drug products. This is in line with global regulators (EMA, FDA) focusing on product safety.

  • In March 2023, DuPont launched PharmaGrade MCC‑Plus, a high-purity grade of MCC for direct-compression tablets. This led to a 15% reduction in process time and was implemented by top-tier global generic manufacturers.

Microcrystalline Cellulose Market Report Scope:

Report Attributes Details
Market Size in 2024 USD 1.21 Billion 
Market Size by 2032 USD 2.12 Billion 
CAGR CAGR of7.23% From 2025 to 2032
Base Year 2024
Forecast Period 2025-2032
Historical Data 2021-2023
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments •By Source (Wood-based, and Non-wood-based)
• By Application (Pharmaceutical, Personal Care & Cosmetics, Food & Beverages, Paints & Coatings, and Others)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles DuPont, FMC Corporation, JRS Pharma, Roquette, DFE Pharma, Asahi Kasei Corporation, Avantor Inc., Mingtai Chemical Co., Ltd., Sigachi Industries, Libraw Pharma